EU Authorized Representative for Korean Medical Device and IVD Manufacturers

Three export families, three different collisions with EU law

Korean device exports into Europe concentrate in dental implantology, aesthetic and dermatological equipment, and in vitro diagnostic reagents and analysers. Each family hits a different part of the European framework, and a manufacturer prepared for one is not prepared for the others.

Dental exporters meet a classification rule with an explicit carve-out. Aesthetic exporters find their products regulated in Europe even without any medical purpose. IVD exporters meet a regulation that moved almost the whole market from self-declaration to notified body involvement. The sections below take them in that order, after one point common to all three.

Notification, certification, approval — and why none of them is a conformity assessment

The Medical Devices Act (Law No. 6909) and its Enforcement Rule sort devices into four classes by risk, harmonised with GHTF and IMDRF principles, and route them through three tiers. Class I devices are notified. Class II devices are certified, largely by the National Institute of Medical Device Safety Information, on a substantial-equivalence or modified-device basis. Class III and Class IV devices, plus novel Class II devices, are approved by MFDS through NIFDS review. Certain Class I and II devices — those needing clinical test reports, digital healthcare products, undefined nomenclature, drug-combination products — are pulled up to MFDS approval regardless.

Two features of that structure travel badly. First, Korean substantial equivalence rests on comparison with a previously approved, certified or notified Korean device; the MDR has no equivalent mechanism and requires clinical evaluation under Article 61 and Annex XIV on its own terms. Second, the Korean class is read off the product classification regulation, whereas the MDR class is derived by applying Annex VIII rules to your intended purpose. A Korean Class II product can land in MDR class IIb, and a Korean Class III product can land in class I.

KGMP and ISO 13485 are close relatives, not interchangeable documents

MFDS publishes its Standards of GMP for Medical Devices alongside separate GMP standards for in vitro diagnostic medical devices and for digital medical devices, and states plainly that the English compilation exists to help manufacturers demonstrate the equivalence of Korea's regulatory system during export and import procedures. The structure will be familiar to any ISO 13485 auditor, and a Korean plant running KGMP properly is not starting from zero.

What KGMP does not produce is an Annex IX file. A notified body assessing your quality management system under Annex IX Chapter I is looking for things a KGMP audit does not systematically generate: a GSPR checklist mapping every requirement in Annex I to specific evidence, a clinical evaluation plan and report, a post-market surveillance plan feeding a PSUR, a risk management file that survives contact with Annex I Section 3, and a person responsible for regulatory compliance meeting the qualification criteria in Article 15. Add the unannounced audits under Annex IX Section 3.4, which have no KGMP counterpart.

Korea's MFDS is an MDSAP affiliate member rather than one of the five participating regulatory authorities, so a Korean quality file also gains nothing through that route — and the EU is only an Official Observer in MDSAP in any case.

Dental implants and the Rule 8 carve-out Korean files usually miss

Implants are class IIb by default under Annex VIII Rule 8, but the rule immediately carves out devices that "are intended to be placed in the teeth, in which case they are classified as class IIa" (MDR Annex VIII, Rule 8). Fixtures and abutments therefore sit a class lower than a Korean exporter usually expects, which is good news and a trap at once, because the same rule pushes upwards anything with a biological effect or that is wholly or mainly absorbed.

That splits a typical Korean dental portfolio across three classes. The titanium fixture is class IIa. The resorbable membrane or bone graft substitute is class III. The surgical kit, if it is a reusable surgical instrument, is class I with notified body involvement limited to reprocessing under Article 52(7). One export catalogue, three conformity assessment routes, three sets of technical documentation.

Aesthetic equipment lands in Annex XVI, where there is no medical purpose to claim

This is the point Korean aesthetic manufacturers most often miss. The MDR regulates a defined list of products that have no intended medical purpose at all. Annex XVI point 5 covers "High intensity electromagnetic radiation (e.g. infra-red, visible light and ultra-violet) emitting equipment intended for use on the human body, including coherent and non-coherent sources, monochromatic and broad spectrum, such as lasers and intense pulsed light equipment, for skin resurfacing, tattoo or hair removal or other skin treatment." Annex XVI also covers dermal fillers, equipment for reducing or destroying adipose tissue, and equipment for brain stimulation.

So a Korean laser or IPL platform sold purely for cosmetic skin treatment is inside the MDR, not outside it, and the common specifications adopted for Annex XVI products apply on top of the general safety and performance requirements. A cosmetic marketing claim does not get you out of the Regulation; it just removes the clinical benefit you would otherwise have argued.

IVD reagents: from mostly self-declared to almost never

Under Regulation (EU) 2017/746 only class A devices are self-declared, and even then a notified body is involved where they are placed on the market sterile. Classes B, C and D all require notified body involvement under Article 48. Rule 4(a) then catches a large slice of the Korean self-test portfolio: "Devices intended for self-testing are classified as class C, except for devices for the detection of pregnancy, for fertility testing and for determining cholesterol level, and devices for the detection of glucose, erythrocytes, leucocytes and bacteria in urine, which are classified as class B." (IVDR Annex VIII, Rule 4(a)).

Read the exception carefully: glucose in urine is class B, but a blood glucose self-test strip is not in the exception list and falls to class C, with the additional technical documentation assessment for self-testing devices under Annex IX Section 5.1. Infectious disease markers for HIV, HBV, HCV and HTLV and ABO/Rh blood grouping reagents — the Korean Class IV list almost exactly — land in IVDR class D, which adds EU reference laboratory verification under Article 48(5).

IVDR Article 11 mirrors MDR Article 11: a manufacturer not established in a Member State may place a device on the Union market only through a sole authorised representative, under a written mandate. If you export both devices and IVDs, you need the mandate to cover both regulations explicitly. Our representation service covers MDR and IVDR under one mandate structure, with class-based annual fees published in advance.

Questions Korean exporters bring to a first MDR meeting

Our KGMP certificate is current. Does a notified body accept it?

As background evidence, yes; as a substitute for the Annex IX audit, no. The practical value is that document control, production control and CAPA already exist in auditable form. What you build from scratch is usually the clinical evaluation, the PMS and PMCF documentation, and the GSPR-to-evidence mapping.

Our device is Class II in Korea. Is it class IIa in Europe?

Sometimes, and the coincidence is not a method. Classification under Annex VIII depends on the intended purpose you write, the duration of contact, invasiveness and whether the device is active. We classify from your intended purpose statement, not from the Korean grade, and we tell you when the rule produces an answer you will not like.

We only sell aesthetic lasers. Are we really inside the MDR?

If the equipment is within Annex XVI point 5 and is intended for use on the human body for skin resurfacing, tattoo or hair removal or other skin treatment, then yes, regardless of the absence of a medical purpose. The route is the same as for a medical device of equivalent risk, and the common specifications add product-specific requirements on top.

Who answers a competent authority in Poland or Germany when a complaint arrives?

We do, as your authorised representative, in the official language the Member State requires. We hold the technical documentation copy, the declaration of conformity and any certificate, forward vigilance reports to you immediately, and keep a PRRC in-house with a deputy so the answer does not wait for a time zone. Reach the desk through our contact page.